- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Current status of theranostics in prostate cancer ; volume:45 ; number:3 ; day:28 ; month:12 ; year:2017 ; pages:471-495 ; date:3.2018
European journal of nuclear medicine and molecular imaging ; 45, Heft 3 (28.12.2017), 471-495, 3.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Virgolini, Irene
- Contributor
-
Decristoforo, Clemens
Haug, Alexander Robert
Fanti, Stefano
Uprimny, Christian
SpringerLink (Online service)
- DOI
-
10.1007/s00259-017-3882-2
- URN
-
urn:nbn:de:1111-201803256180
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Virgolini, Irene
- Decristoforo, Clemens
- Haug, Alexander Robert
- Fanti, Stefano
- Uprimny, Christian
- SpringerLink (Online service)
Other Objects (12)
Theranostics in prostate cancer
The Current Status of Prostate Cancer
Chemodynamic nanomaterials for cancer theranostics
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multifunctional SPIONs for Theranostics in Cancer
Correction: Current status and future outlook of ultrasound treatment for prostate cancer
Current challenges in prostate cancer: an interview with Prostate Cancer UK
Persistent luminescence nanoparticles for cancer theranostics application
Norepinephrine transporter–targeted cancer theranostics — new horizons
A Multifunctional Biodegradable Nanocomposite for Cancer Theranostics
Theranostics in prostate cancer
The Current Status of Prostate Cancer
Chemodynamic nanomaterials for cancer theranostics
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multifunctional SPIONs for Theranostics in Cancer
Correction: Current status and future outlook of ultrasound treatment for prostate cancer
Current challenges in prostate cancer: an interview with Prostate Cancer UK
Persistent luminescence nanoparticles for cancer theranostics application
Norepinephrine transporter–targeted cancer theranostics — new horizons
A Multifunctional Biodegradable Nanocomposite for Cancer Theranostics
Theranostics in prostate cancer
The Current Status of Prostate Cancer
Chemodynamic nanomaterials for cancer theranostics
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multifunctional SPIONs for Theranostics in Cancer
Correction: Current status and future outlook of ultrasound treatment for prostate cancer
Current challenges in prostate cancer: an interview with Prostate Cancer UK
Persistent luminescence nanoparticles for cancer theranostics application
Norepinephrine transporter–targeted cancer theranostics — new horizons